DrugPatentWatch Database Preview
Email this page to a colleagueSee Plans and Pricing
« Back to Dashboard
Acetamide is an investigational drug.
There have been 13 clinical trials for Acetamide. The most recent clinical trial was a Phase 2 trial, which was initiated on February 1st 2016.
The most common disease conditions in clinical trials are Rectal Neoplasms, Substance-Related Disorders, and Liver Failure, Acute. The leading clinical trial sponsors are California Pacific Medical Center Research Institute, City of Hope Medical Center, and Virginia Clinical Research, Inc.
There are three US patents protecting this investigational drug and thirty-three international patents.
Recent Clinical Trials for Acetamide
|Modafinil's Effects on Cognition in Remitted MDD||Ontario Ministry of Health and Long Term Care||Phase 3|
|Modafinil's Effects on Cognition in Remitted MDD||The Canadian Biomarker Integration Network in Depression||Phase 3|
|Modafinil's Effects on Cognition in Remitted MDD||St. Michael's Hospital, Toronto||Phase 3|
Top disease conditions for Acetamide
Top clinical trial sponsors for Acetamide
|Drugname||Patent Number||Patent Title||Patent Assignee||Estimated Expiration|
|Acetamide||Start Trial||Method for processing silver halide color photographic material for prints||Fuji Photo Film Co., Ltd. (Kanagawa, JP)||Start Trial|
|Acetamide||Start Trial||1-aryl-1-hydroxy-1-substitute d-3-(4-substituted-1-piperazinyl)-2-propanones and their use in treatment of neurogenic bladder disorders||Marion Laboratories, Inc. (Kansas City, MO)||Start Trial|
|Acetamide||Start Trial||7-substituted bicyclic pyrazolidinones||Eli Lilly and Company (Indianapolis, IN)||Start Trial|
|Acetamide||Start Trial||Novel esters of phenylalkanoic acid||Ono Pharmaceutical Co., Ltd. (Osaka, JP)||Start Trial|
|Acetamide||Start Trial||Substituted propane-phosphinic acid compounds||Ciba-Geigy Corporation (Ardsley, NY)||Start Trial|
|>Drugname||>Patent Number||>Patent Title||>Patent Assignee||>Estimated Expiration|
|Drugname||Country||Document Number||Estimated Expiration||Related US Patent|
|Acetamide||European Patent Office||0231861||2006-01-27||Start Trial|
|>Drugname||>Country||>Document Number||>Estimated Expiration||>Related US Patent|